kTMP in Chronic Stroke
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07277595
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Arm Weakness as a Consequence of Stroke
- Chronic Stroke Patients
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- kTMP sham stimulation 9 weeks + active stimulation 9 weeks — DEVICEkTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation
- kTMP 18 weeks — DEVICEParticipants receive kTMP active stimulation for 18 weeks
Study Details
kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- May 2026
- Primary completion
- Aug 1, 2030
- Completion
- Aug 1, 2030
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active TreatmentActive treatment with kTMP for 18 weeks
- Other: Crossover TreatmentInitial 9 weeks will receive sham kTMP treatment, followed by 9 weeks of active kTMP treatment.
Primary Outcome Measure
Fugl Meyer Assessment [ Time Frame: Enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34. ]
Central Contacts
- Karunesh Ganguly, MD, PhD415-514-1252
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 | - |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsPHASE1/PHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Traumatic Brain Injury and Stroke Long Term OutcomeRecruiting · Centre for Neuro Skills · Encino, California
- ECoG BMI for Motor and Speech ControlRecruiting · Karunesh Ganguly · San Francisco, California